Follow

What could go wrong ?
« Home DNA test results from the 5 million customers of 23andMe will now be used by drug giant GlaxoSmithKline to design new drugs, the two companies announce. »

nbcnews.com/news/amp/ncna89453

@xavcc I'm trying to act surprised but I can't because the terms for those 'send us your spit in the post' services do say the sample can be used for whatever they want.
@thatbrickster @xavcc Yep. And how they like to get back at them raciss folk! So it doesn't surprise me.
@XavCC don't talk to or give your genetic code to strangers, this isn't hard.
@XavCC

One presumes that opting out of this is as simple as not buying the health-screening package. Or I can go find another genetic-history company, I guess, when I decide to blow $100 on a lark.

@XavCC "The company was founded by Linda Avey, Paul Cusenza and Anne Wojcicki in 2006 to provide genetic testing and interpretation to individual consumers. In 2007, #Google invested $3,900,000 in the company, along with Genentech, New Enterprise Associates, and Mohr Davidow Ventures. Wojcicki was married to Google co-founder Sergey Brin at the time."

en.wikipedia.org/wiki/23andMe

#FuckOffGoogle

@FuckOffGoogle
Ok well done !

I'm running to wikify those informations now

I didn't realise 23andMe sold people's DNA. There but for the grace...

@XavCC I would not call myself a corporate apologist by any measure, but it may be worth noting that the process of sharing your results is opt-in

@whjms
That is indeed a good point. But can we be satisfied with that alone? Especially when this one good point is coated with marketing to hide weaknesses?

Sign in to participate in the conversation
La Quadrature du Net - Mastodon - Media Fédéré

Bienvenue dans le media fédéré de la Quadrature du Net association de défense des libertés. Les inscriptions sont ouvertes et libres.
Tout compte créé ici pourra a priori discuter avec l'ensemble des autres instances de Mastodon de la fédération, et sera visible sur les autres instances.
Nous maintiendrons cette instance sur le long terme.